Age-related muscle loss is now a diagnosable disease. One treatment has strong backing.

The gradual loss of muscle with age used to be treated as an inevitable background fact of getting older. It now has a clinical name — sarcopenia — a formal definition, diagnostic cut-offs, and its own set of practice guidelines. And when those guidelines rank what actually works to treat it, the answer is unusually decisive: resistance exercise is strongly recommended, and almost everything else in the sarcopenia marketplace is either weakly supported or not recommended at all.

From "just ageing" to a diagnosis

The European Working Group on Sarcopenia in Older People first defined the condition in 2010 and revised the definition in 2018 [s1]. The updated consensus made a pointed shift: it put low muscle strength — not muscle size — at the centre of the diagnosis, using low muscle quantity or quality to confirm it and poor physical performance to mark severe cases [s1]. In other words, what matters most is not how big a muscle is but what it can do. The revision provided specific cut-off points for the measurements used to identify and grade the condition [s1].

Sarcopenia is common. International clinical practice guidelines estimate it affects roughly 6% to 22% of older adults, and recommend rapid screening with simple tools such as gait speed or the SARC-F questionnaire before confirming with an accepted measurement definition [s2].

What the guidelines say to do about it

This is where the evidence becomes refreshingly clear. The international guideline task force, grading each option by the strength of its evidence, made one strong recommendation for treatment: resistance-based physical activity — that is, training muscles against a load [s2]. Everything else was hedged. Protein supplementation or a protein-rich diet earned only a conditional recommendation. And for two of the interventions most heavily marketed to older adults worried about muscle, the task force declined to recommend at all: it gave no recommendation for vitamin D supplementation and none for anabolic hormone prescription, citing a lack of robust evidence to judge other options [s2].

The hierarchy matters because it inverts the usual consumer emphasis. Protein powders, amino-acid blends, vitamin D and hormone therapies are sold hard to the ageing muscle market; the actual intervention with strong backing is the one that cannot be bottled. Protein and diet play a supporting, conditional role — muscle needs the raw material — but the guideline is explicit that they are secondary to the loading stimulus of resistance training [s2].

Why loading is the active ingredient

The biology fits the recommendation. Muscle is built and maintained in response to mechanical demand; remove the demand, and muscle is lost, which is why bed rest and inactivity accelerate the decline so sharply. Resistance training supplies that demand directly. Protein supplies the building blocks, but without the signal to build, extra protein has less to act on — which is a plausible reason the trials support exercise more strongly than supplementation alone [s2].

None of this requires a gym or heavy barbells. "Resistance-based physical activity" spans bands, bodyweight, machines and progressively loaded functional movements; the principle is progressive challenge to the muscles, not a particular setting.

The honest bottom line

Age-related muscle loss is real, consequential — it feeds into frailty, falls and loss of independence — and, unlike some conditions of ageing, it has a treatment with strong evidence behind it. That treatment is resistance exercise [s2]. Protein and diet help support it; vitamin D and hormone therapies are not endorsed by the guideline for this purpose on current evidence [s2]. Anyone considering how to start, particularly with existing health conditions, should work out the specifics with a clinician or a qualified trainer rather than from an article — but the direction the evidence points is unambiguous, and it is not toward a supplement shelf.

This article is informational and is not medical advice.